In one paragraphArticle in Clinical rheumatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
16 authors at 2 institutions in 1 country.
David Vega-MoralesUniversidad Autónoma de Nuevo León, Rheumatology Service at Hospital Universitario "Dr, José Eleuterio González", Gonzalitos 235 N. 64020 Monterrey, Nuevo León, Mexico. drdavidvega@yahoo.com.mx.ORCID http://orcid.org/0000-0003-0651-2202 María Del Carmen Larios-ForteRadiology Department, Hospital Regional Monterrey, Instituto de Seguridad Y Servicios Sociales de los Trabajadores del Estado, Monterrey, Nuevo León, Mexico.ORCID http://orcid.org/0000-0001-9999-0179 Lorena Pérez-BarbosaUniversidad Autónoma de Nuevo León, Rheumatology Service at Hospital Universitario "Dr, José Eleuterio González", Gonzalitos 235 N. 64020 Monterrey, Nuevo León, Mexico.ORCID http://orcid.org/0000-0001-5033-9588 Jorge Antonio Esquivel-ValerioUniversidad Autónoma de Nuevo León, Rheumatology Service at Hospital Universitario "Dr, José Eleuterio González", Gonzalitos 235 N. 64020 Monterrey, Nuevo León, Mexico.ORCID http://orcid.org/0000-0002-3124-0395 Mario Alberto Garza-ElizondoUniversidad Autónoma de Nuevo León, Rheumatology Service at Hospital Universitario "Dr, José Eleuterio González", Gonzalitos 235 N. 64020 Monterrey, Nuevo León, Mexico.ORCID http://orcid.org/0000-0001-5480-3050 Cassandra Michelle Skinner-TaylorUniversidad Autónoma de Nuevo León, Rheumatology Service at Hospital Universitario "Dr, José Eleuterio González", Gonzalitos 235 N. 64020 Monterrey, Nuevo León, Mexico.ORCID http://orcid.org/0000-0002-1800-0020 Brenda Roxana Vázquez-FuentesUniversidad Autónoma de Nuevo León, Rheumatology Service at Hospital Universitario "Dr, José Eleuterio González", Gonzalitos 235 N. 64020 Monterrey, Nuevo León, Mexico.ORCID http://orcid.org/0000-0002-3258-881X Diana Elsa Flores-AlvaradoUniversidad Autónoma de Nuevo León, Rheumatology Service at Hospital Universitario "Dr, José Eleuterio González", Gonzalitos 235 N. 64020 Monterrey, Nuevo León, Mexico.ORCID http://orcid.org/0000-0003-1181-4977 Miguel Ángel Villarreal-AlarcónUniversidad Autónoma de Nuevo León, Rheumatology Service at Hospital Universitario "Dr, José Eleuterio González", Gonzalitos 235 N. 64020 Monterrey, Nuevo León, Mexico.ORCID http://orcid.org/0000-0001-6986-5377 Iván de Jesús Hernández-GalarzaUniversidad Autónoma de Nuevo León, Rheumatology Service at Hospital Universitario "Dr, José Eleuterio González", Gonzalitos 235 N. 64020 Monterrey, Nuevo León, Mexico.ORCID http://orcid.org/0000-0001-9597-8789 Luis Iván Lozano-PlataUniversidad Autónoma de Nuevo León, Rheumatology Service at Hospital Universitario "Dr, José Eleuterio González", Gonzalitos 235 N. 64020 Monterrey, Nuevo León, Mexico.
Martha Mariana Castañeda-MartínezUniversidad Autónoma de Nuevo León, Rheumatology Service at Hospital Universitario "Dr, José Eleuterio González", Gonzalitos 235 N. 64020 Monterrey, Nuevo León, Mexico.ORCID http://orcid.org/0000-0001-8158-7170 Diana Daniela Castañeda-MartínezUniversidad Autónoma de Nuevo León, Rheumatology Service at Hospital Universitario "Dr, José Eleuterio González", Gonzalitos 235 N. 64020 Monterrey, Nuevo León, Mexico.ORCID http://orcid.org/0000-0003-4822-0777 Pablo Herrera-SandateUniversidad Autónoma de Nuevo León, Rheumatology Service at Hospital Universitario "Dr, José Eleuterio González", Gonzalitos 235 N. 64020 Monterrey, Nuevo León, Mexico.ORCID http://orcid.org/0000-0002-3711-4883 Jesus Alberto Cardenas-de la GarzaUniversidad Autónoma de Nuevo León, Rheumatology Service at Hospital Universitario "Dr, José Eleuterio González", Gonzalitos 235 N. 64020 Monterrey, Nuevo León, Mexico.ORCID http://orcid.org/0000-0002-5099-0079 Dionicio Ángel Galarza-DelgadoUniversidad Autónoma de Nuevo León, Rheumatology Service at Hospital Universitario "Dr, José Eleuterio González", Gonzalitos 235 N. 64020 Monterrey, Nuevo León, Mexico.ORCID http://orcid.org/0000-0001-9714-2109 Universidad Autónoma de Nuevo León · MXInstitute for Social Security and Services for State Workers · MX
Funding
Dirección General de Planeación y Proyectos Estratégicos en el Programa para el Desarrollo Profesional Docente para el Tipo Superior (PRODEP) Cuerpos Académicos (CA) number 136
6 · The paper itselfAbstract
INTRODUCTION/
objectivesFirst-degree relatives (FDR) of patients with rheumatoid arthritis (RA) are at increased risk of RA diagnosis. Magnetic resonance imaging (MRI) has been proposed as a useful tool to detect subclinical synovitis and bone abnormalities as predictors of progression to RA. The presence of grade ≥ 2 bone erosions in RA MRI scoring system (RAMRIS) was reported to be RA-specific. We aim to describe the prevalence and characteristics of MRI findings in RA patients and FDR.
methodsA cross-sectional and exploratory study of 60 individuals was performed in 38 RA patients and 22 FDR with hand arthralgia without clinical arthritis and positive rheumatoid factor or anticitrullinated protein antibodies. All patients underwent an MRI and were evaluated for synovitis, bone erosion, and bone marrow edema. We evaluated second to fifth metacarpophalangeal joints of the dominant hand according to RAMRIS.
resultsAmong the total population, eighteen (30%) subjects had grade ≥ 2 bone erosions, and 42 (70%) had at least one erosion of any grade. In patients with grade ≥ 2 bone erosions, 12 (31.6%) were from RA patients and 6 (27.2%) from FDR (p = 0.72). In patients with erosions of any grade, 26 (68.4%) were from RA patients and 15 (68.2%) were from FDR (p = 0.98).
conclusionA high prevalence of bone erosions was found in RA patients' FDR who had symptoms without clinical arthritis and positive serology. MRI might be helpful in this population for an early detection of RA-specific erosions. The prognosis and the treatment decisions in these subjects should be elucidated. KEY POINTS: • First-degree relatives (FDR) of rheumatoid arthritis (RA) patients with positive serology and joint symptoms constitute a select subpopulation of individuals with an increased risk of developing RA. • Magnetic resonance imaging (MRI) of FDR shows a high prevalence of bone erosions of any grade, grade ≥ 2 erosions, and synovitis. • MRI might be helpful in FDR of RA patients to screen for the presence of RA-specific erosions or clinically undetectable synovitis.
Indexed as
Arthritis, RheumatoidSynovitisCross-Sectional StudiesHumansMagnetic Resonance ImagingMetacarpophalangeal JointSeverity of Illness IndexWrist JointArthralgiaMagnetic resonance imagingRelativesRheumatoid arthritisSynovitis
Identifiers
PMID35088207
OpenAlexW4210633883
What OpenQuestion holds
Textmetadata
Read underepoch 390